BIO-RAD LABORATORIES, INC. (BIO) Current Ratio
- Current ratio · latest quarter: Value 3.14×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 3.14× | Current assets / current liabilities. $3.02B ÷ $961.30M ≈ 3.14× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 3.02B USD | Assets, Current |
| Current obligations | 961.30M USD | Liabilities, Current |
| Cash and equivalents | 517.00M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 441.80M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | 780.60M USD | Inventory, Net |
| Payables | 143.50M USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) | Long-term Debt, Current Maturities |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $3.02B | $961.30M | $517.00M | (m) | $441.80M | $780.60M | $143.50M | (m) | 3.14× |
| 2026-03-31 | $2.94B | $917.00M | $507.20M | (m) | $426.20M | $770.50M | $133.10M | (m) | 3.21× |
| 2025-12-31 | $2.91B | $517.00M | $529.80M | (m) | $460.60M | $740.70M | $129.00M | (m) | 5.62× |
| 2025-09-30 | $2.84B | $522.30M | $395.80M | (m) | $464.70M | $783.20M | $128.80M | (m) | 5.44× |
| 2025-06-30 | $2.81B | $548.90M | $369.30M | (m) | $469.90M | $798.80M | $139.30M | (m) | 5.12× |
| 2025-03-31 | $3.04B | $506.60M | $521.40M | (m) | $424.70M | $790.10M | $137.90M | (m) | 5.99× |
| 2024-12-31 | $3.03B | $467.80M | $488.10M | (m) | $452.50M | $760.00M | $122.30M | (m) | 6.48× |
| 2024-09-30 | $3.06B | $497.94M | $410.38M | (m) | $461.94M | $804.28M | $122.19M | (m) | 6.14× |
| 2024-06-30 | $3.06B | $486.96M | $406.91M | (m) | $445.51M | $803.69M | $126.69M | (m) | 6.28× |
| 2024-03-31 | $3.06B | $466.15M | $433.28M | (m) | $444.81M | $783.37M | $102.75M | (m) | 6.57× |
| 2023-12-31 | $3.05B | $522.80M | $403.80M | (m) | $489.00M | $780.50M | $144.60M | (m) | 5.83× |
| 2023-09-30 | $3.15B | $558.18M | $457.85M | (m) | $457.40M | $775.82M | $111.86M | (m) | 5.64× |
| 2023-06-30 | $3.14B | $581.98M | $390.00M | (m) | $491.57M | $776.60M | $149.53M | (m) | 5.39× |
| 2023-03-31 | $3.28B | $589.62M | $464.14M | (m) | $498.27M | $752.94M | $160.98M | (m) | 5.56× |
| 2022-12-31 | $3.16B | $568.71M | $434.21M | (m) | $494.64M | $719.32M | $135.04M | (m) | 5.55× |
| 2022-09-30 | $3.14B | $570.68M | $517.94M | (m) | $432.30M | $685.85M | $142.75M | (m) | 5.50× |
| 2022-06-30 | $3.25B | $613.71M | $596.58M | (m) | $450.32M | $657.13M | $158.26M | (m) | 5.30× |
| 2022-03-31 | $3.30B | $648.33M | $802.32M | (m) | $464.11M | $605.49M | $160.65M | (m) | 5.10× |
| 2021-12-31 | $1.99B | $680.94M | $470.78M | (m) | $423.54M | $572.24M | $141.94M | (m) | 2.92× |
| 2021-09-30 | $2.47B | $649.92M | $859.90M | (m) | $417.71M | $588.91M | $136.40M | (m) | 3.79× |
| 2021-06-30 | $2.29B | $587.05M | $732.84M | (m) | $399.31M | $598.99M | $133.46M | (m) | 3.90× |
| 2021-03-31 | $2.18B | $609.89M | $673.47M | (m) | $408.14M | $605.16M | $138.49M | (m) | 3.57× |
| 2020-12-31 | $2.14B | $631.54M | $662.21M | (m) | $419.42M | $622.25M | $139.45M | (m) | 3.39× |
| 2020-09-30 | $2.32B | $986.66M | $840.33M | (m) | $402.24M | $640.23M | $132.99M | (m) | 2.36× |
| 2020-06-30 | $2.13B | $926.89M | $607.58M | (m) | $360.85M | $628.40M | (m) | (m) | 2.30× |
| 2020-03-31 | $2.08B | $869.25M | $603.55M | (m) | $380.48M | $557.03M | (m) | (m) | 2.40× |
| 2019-12-31 | $2.18B | $905.50M | $660.67M | (m) | $392.67M | $554.01M | $107.01M | (m) | 2.41× |
| 2019-09-30 | $2.05B | $434.04M | $561.07M | (m) | $356.02M | $587.99M | (m) | (m) | 4.72× |
| 2019-06-30 | $2.09B | $445.98M | $580.68M | (m) | $377.90M | $589.90M | (m) | (m) | 4.68× |
| 2019-03-31 | $2.03B | $444.31M | $455.89M | (m) | $391.70M | $590.44M | (m) | (m) | 4.57× |
| 2018-12-31 | $2.02B | $450.80M | $431.53M | (m) | $392.44M | $583.82M | $122.45M | (m) | 4.49× |
| 2018-09-30 | $2.03B | $453.16M | $434.52M | (m) | $381.53M | $601.05M | (m) | (m) | 4.49× |
| 2018-06-30 | $1.99B | $442.42M | $403.01M | (m) | $404.09M | $591.43M | (m) | (m) | 4.50× |
| 2018-03-31 | $1.98B | $456.20M | $407.27M | (m) | $430.36M | $612.22M | (m) | (m) | 4.33× |
| 2017-12-31 | $1.98B | $502.70M | $383.82M | (m) | $464.85M | $594.80M | $135.18M | (m) | 3.93× |
| 2017-09-30 | $1.89B | $466.46M | $328.89M | (m) | $419.71M | $601.57M | (m) | (m) | 4.06× |
| 2017-06-30 | $1.83B | $455.11M | $321.58M | (m) | $392.84M | $580.58M | (m) | (m) | 4.01× |
| 2017-03-31 | $1.73B | $407.50M | $291.66M | (m) | $373.44M | $559.82M | (m) | (m) | 4.25× |
| 2016-12-31 | $1.84B | $471.32M | $456.26M | (m) | $372.35M | $524.96M | $133.11M | (m) | 3.91× |
| 2016-09-30 | $1.85B | $442.72M | $417.94M | (m) | $367.66M | $556.36M | (m) | (m) | 4.18× |
| 2016-06-30 | $1.81B | $410.40M | $418.65M | (m) | $366.28M | $541.51M | (m) | (m) | 4.40× |
| 2016-03-31 | $1.78B | $400.89M | $403.62M | (m) | $381.10M | $533.31M | (m) | (m) | 4.43× |
| 2015-12-31 | $1.78B | $441.35M | $457.55M | (m) | $391.49M | $490.22M | $122.39M | (m) | 4.03× |
| 2015-09-30 | $1.79B | $435.24M | $507.33M | (m) | $341.55M | $512.74M | (m) | (m) | 4.12× |
| 2015-06-30 | $1.74B | $403.89M | $450.13M | (m) | $354.16M | $500.98M | (m) | (m) | 4.31× |
| 2015-03-31 | $1.70B | $416.88M | $425.73M | (m) | $342.22M | $478.38M | (m) | (m) | 4.08× |
| 2014-12-31 | $1.72B | $446.76M | $413.25M | (m) | $377.64M | $471.00M | $128.61M | (m) | 3.84× |
| 2014-09-30 | $1.76B | $503.78M | $424.59M | (m) | $354.40M | $516.05M | $126.64M | (m) | 3.50× |
| 2014-06-30 | $1.77B | $480.25M | $384.67M | (m) | $378.89M | $520.64M | $125.46M | $200.00K | 3.68× |
| 2014-03-31 | $1.77B | $481.25M | $364.51M | (m) | $383.93M | $513.85M | $130.86M | $200.00K | 3.67× |
| 2013-12-31 | $1.76B | $487.47M | $331.55M | (m) | $422.66M | $516.25M | $148.51M | (m) | 3.61× |
| 2013-09-30 | $1.67B | $462.88M | $291.79M | (m) | $383.47M | $523.50M | $131.90M | $200.00K | 3.62× |
| 2013-06-30 | $1.90B | $431.24M | $367.00M | (m) | $395.97M | $484.67M | $129.12M | $200.00K | 4.41× |
| 2013-03-31 | $1.87B | $446.74M | $368.63M | (m) | $377.55M | $467.32M | $119.34M | $200.00K | 4.18× |
| 2012-12-31 | $1.94B | $472.40M | $463.39M | (m) | $398.74M | $455.12M | $130.87M | $200.00K | 4.10× |
| 2012-09-30 | $1.85B | $433.67M | $426.46M | (m) | $375.80M | $458.43M | $113.28M | $300.00K | 4.26× |
| 2012-06-30 | $1.81B | $417.18M | $456.49M | (m) | $373.82M | $449.46M | $119.45M | $400.00K | 4.34× |
| 2012-03-31 | $1.82B | $444.08M | $533.81M | (m) | $387.62M | $463.37M | $109.57M | $400.00K | 4.09× |
| 2011-12-31 | $1.80B | $459.12M | $574.23M | (m) | $398.67M | $433.51M | $129.12M | $600.00K | 3.92× |
| 2011-09-30 | $1.88B | $415.33M | $671.03M | (m) | (m) | $445.58M | $113.48M | $700.00K | 4.52× |
| 2011-06-30 | $1.89B | $442.84M | $670.30M | (m) | (m) | $449.34M | $120.51M | $700.00K | 4.27× |
| 2011-03-31 | $1.80B | $427.59M | $627.91M | (m) | (m) | $429.98M | (m) | (m) | 4.20× |
| 2010-12-31 | $1.98B | $666.63M | $906.55M | (m) | (m) | $398.10M | $113.44M | $233.10M | 2.96× |
| 2010-09-30 | $1.65B | $410.69M | $630.64M | (m) | (m) | $402.88M | (m) | (m) | 4.02× |
| 2010-06-30 | $1.56B | $389.50M | $614.22M | (m) | (m) | $370.27M | (m) | (m) | 3.99× |
| 2009-12-31 | $1.56B | $419.97M | $649.94M | (m) | (m) | $351.21M | (m) | $737.92M | 3.72× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.